OpenURL Connection Search

Select item for more details and to access through your institution.

Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk.
Published in:
Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01030-w
By:
- Callander, Natalie S.;
- Silbermann, Rebecca;
- Kaufman, Jonathan L.;
- Godby, Kelly N.;
- Laubach, Jacob;
- Schmidt, Timothy M.;
- Sborov, Douglas W.;
- Medvedova, Eva;
- Reeves, Brandi;
- Dhakal, Binod;
- Rodriguez, Cesar;
- Chhabra, Saurabh;
- Chari, Ajai;
- Bal, Susan;
- Anderson Jr, Larry D.;
- Dholaria, Bhagirathbhai R.;
- Nathwani, Nitya;
- Hari, Parameswaran;
- Shah, Nina;
- Bumma, Naresh
Publication type:
Article
Ponatinib sensitizes myeloma cells to MEK inhibition in the high-risk VQ model.
Published in:
Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-14114-z
By:
- Flietner, Evan;
- Wen, Zhi;
- Rajagopalan, Adhithi;
- Jung, Oisun;
- Watkins, Lyndsay;
- Wiesner, Joshua;
- You, Xiaona;
- Zhou, Yun;
- Sun, Yuqian;
- Kingstad-Bakke, Brock;
- Callander, Natalie S.;
- Rapraeger, Alan;
- Suresh, M.;
- Asimakopoulos, Fotis;
- Zhang, Jing
Publication type:
Article
Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.
Published in:
Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1005031
By:
- Muhammad Umair Mushtaq;
- MoazzamShahzad;
- Shah, Amna Y.;
- Chaudhary, Sibgha Gull;
- Muhammad U. Zafar;
- Anwar, Iqra;
- Neupane, Karun;
- Khalid, Ayesha;
- Ahmed, Nausheen;
- Bansal, Rajat;
- Balusu, Ramesh;
- Singh, Anurag K.;
- Abhyankar, Sunil H.;
- Callander, Natalie S.;
- Hematti, Peiman;
- McGuirk, Joseph P.
Publication type:
Article
Recommendations on prevention of infections during chimeric antigen receptor T‐cell and bispecific antibody therapy in multiple myeloma.
Published in:
British Journal of Haematology, 2023, v. 203, n. 5, p. 736, doi. 10.1111/bjh.18909
By:
- Mohan, Meera;
- Chakraborty, Rajshekhar;
- Bal, Susan;
- Nellore, Anoma;
- Baljevic, Muhamed;
- D'Souza, Anita;
- Pappas, Peter G.;
- Berdeja, Jesus G.;
- Callander, Natalie;
- Costa, Luciano J.
Publication type:
Article
Novel prognostic scoring system for autologous hematopoietic cell transplantation in multiple myeloma.
Published in:
British Journal of Haematology, 2020, v. 191, n. 3, p. 442, doi. 10.1111/bjh.16987
By:
- Dhakal, Binod;
- D'Souza, Anita;
- Callander, Natalie;
- Chhabra, Saurabh;
- Fraser, Raphael;
- Davila, Omar;
- Anderson, Kenneth;
- Assal, Amer;
- Badawy, Sherif M.;
- Berdeja, Jesus;
- Cerny, Jan;
- Comenzo, Raymond;
- Chakraborty, Rajshekhar;
- Peter Gale, Robert;
- Kamble, Rammurti;
- Kharfan‐Dabaja, Mohamed A.;
- Krem, Maxwell;
- Ganguly, Siddhartha;
- Janakiram, Murali;
- Kansagra, Ankit
Publication type:
Article
Bone marrow stromal cells from multiplemyeloma patients uniquely induce bortezomibresistant NF-κB activity in myeloma cells.
Published in:
Molecular Cancer, 2010, v. 9, p. 176, doi. 10.1186/1476-4598-9-176
By:
- Markovina, Stephanie;
- Callander, Natalie S.;
- O'Connor, Shelby L.;
- Guangwu Xu;
- Yufang Shi;
- Leith, Catherine P.;
- KyungMann Kim;
- Trivedi, Parul;
- Kim, Jaehyup;
- Hematti, Peiman;
- Miyamoto, Shigeki
Publication type:
Article
Flat-dose granulocyte colony-stimulating factor evaluation after autologous hematopoietic stem cell transplant in multiple myeloma patients: Does one dose fit all?
Published in:
Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1716, doi. 10.1177/1078155220968611
By:
- Kim, Olivia M;
- Jared, Jason R;
- Hennes, Emily R;
- Ninos, Cameron L;
- Przybylski, Daniel J;
- Callander, Natalie S
Publication type:
Article
Granulocyte colony-stimulating factor utilization postautologous hematopoietic stem cell transplant in multiple myeloma patients: Does one size fit all?
Published in:
Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 5, p. 1135, doi. 10.1177/1078155218781888
By:
- Jackson, Emily R;
- Jared, Jason R;
- Piccolo, Jennifer K;
- Mably, Mary S;
- Reed, Michael P;
- Woo, Kaitlin M;
- Callander, Natalie S
Publication type:
Article
Utilization and evaluation of noncore chemotherapy regimens within an academic medical center.
Published in:
Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 7, p. 518, doi. 10.1177/1078155216657679
By:
- Jared, Jason R.;
- Mably, Mary S.;
- Makielski, Rory;
- Reed, Michael P.;
- Fallon, Michael J.;
- Liu, Glenn;
- Mulkerin, Daniel;
- Callander, Natalie S.
Publication type:
Article
Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma.
Published in:
American Journal of Hematology, 2023, v. 98, n. 1, p. 140, doi. 10.1002/ajh.26596
By:
- D'Souza, Anita;
- Brazauskas, Ruta;
- Stadtmauer, Edward A.;
- Pasquini, Marcelo C.;
- Hari, Parameswaran;
- Bashey, Asad;
- Callander, Natalie;
- Devine, Steven;
- Efebera, Yvonne;
- Ganguly, Siddhartha;
- Gasparetto, Cristina;
- Geller, Nancy;
- Horowitz, Mary M.;
- Koreth, John;
- Landau, Heather;
- Brunstein, Claudio;
- McCarthy, Philip;
- Qazilbash, Muzaffar H.;
- Giralt, Sergio;
- Krishnan, Amrita
Publication type:
Article
Impact of autologous hematopoietic cell transplantation on disease burden quantified by next‐generation sequencing in multiple myeloma treated with quadruplet therapy.
Published in:
American Journal of Hematology, 2022, v. 97, n. 9, p. 1170, doi. 10.1002/ajh.26640
By:
- Bal, Susan;
- Dhakal, Binod;
- Silbermann, Rebecca W.;
- Schmidt, Timothy M.;
- Dholaria, Bhagirathbhai;
- Giri, Smith;
- Chhabra, Saurabh;
- Medvedova, Eva;
- Godby, Kelly N.;
- D'Souza, Anita;
- Hall, Aric C.;
- Hardwick, Pamela;
- Omel, Jim;
- Cornell, Robert F.;
- Hari, Parameswaran;
- Callander, Natalie S.;
- Costa, Luciano J.
Publication type:
Article
The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance.
Published in:
American Journal of Hematology, 2021, v. 96, n. 7, p. 846, doi. 10.1002/ajh.26155
By:
- Castillo, Jorge J.;
- Callander, Natalie S.;
- Baljevic, Muhamed;
- Sborov, Douglas W.;
- Kumar, Shaji
Publication type:
Article
Implementation of a chemotherapy stewardship process.
Published in:
American Journal of Health-System Pharmacy, 2020, v. 77, n. 15, p. 1243, doi. 10.1093/ajhp/zxaa157
By:
- Hennes, Emily R;
- Reed, Michael;
- Mably, Mary;
- Jared, Jason;
- Bergsbaken, Jason J;
- Deming, Dustin;
- Callander, Natalie;
- O'Regan, Ruth
Publication type:
Article
Determining Administration of BCMA, T-Cell Engagers in R/R Multiple Myeloma.
Published in:
Oncology (08909091), 2024, v. 38, n. 9, p. 349
By:
- Mikhael, Joseph;
- Baljevic, Muhamed;
- Landgren, C. Ola;
- Rodriquez Valdes, Cesar;
- Usmani, Saad Z.;
- Callander, Natalie;
- Richter, Joshua
Publication type:
Article
Inpatient vs Outpatient Use of Teclistamab in Multiple Myeloma.
Published in:
Oncology (08909091), 2024, v. 38, n. 2, p. 71
By:
- Chari, Ajai;
- Callander, Natalie;
- Pianko, Matthew James;
- Schmidt, Timothy;
- Landgren, C. Ola;
- Costello, Caitlin
Publication type:
Article
The Management of Relapsed and Refractory Multiple Myeloma.
Published in:
Oncology (08909091), 2023, v. 37, n. 4, p. 164, doi. 10.46883/2023.25920991
By:
- Gahvari, Zhubin J.;
- Callander, Natalie S.
Publication type:
Article
Timelapse viability assay to detect division and death of primary multiple myeloma cells in response to drug treatments with single cell resolution.
Published in:
Integrative Biology, 2022, v. 14, n. 3, p. 49, doi. 10.1093/intbio/zyac006
By:
- Mark, Christina;
- Callander, Natalie S;
- Chng, Kenny;
- Miyamoto, Shigeki;
- Warrick, Jay
Publication type:
Article
Update on the current and future use of CAR‐T to treat multiple myeloma.
Published in:
European Journal of Haematology, 2024, v. 112, n. 4, p. 493, doi. 10.1111/ejh.14145
By:
- Gahvari, Zhubin;
- Brunner, Matthew;
- Schmidt, Timothy;
- Callander, Natalie S.
Publication type:
Article
Immunohistochemical identification of tissue factor in solid tumors.
Published in:
1992
By:
- Callander, Natalie S.;
- Varki, Nissi;
- Vijaya Rao, L. Mohan;
- Callander, N S;
- Varki, N;
- Rao, L V
Publication type:
journal article
Thalidomide Maintenance Following High-Dose Melphalan with Autologous Stem Cell Support in Myeloma.
Published in:
Clinical Lymphoma & Myeloma, 2008, v. 8, n. 3, p. 153
By:
- Chang, Julie E.;
- Juckett, Mark B.;
- Callander, Natalie S.;
- Kahl, Brad S.;
- Gangnon, Ronald E.;
- Mitchell, Teri L.;
- Longo, Walter L.
Publication type:
Article
Bone Marrow Stromal Cells Transcriptionally Repress ESR1 but Cannot Overcome Constitutive ESR1 Mutant Activity.
Published in:
Endocrinology, 2019, v. 160, n. 10, p. 2427, doi. 10.1210/en.2019-00299
By:
- Lung, David K;
- Warrick, Jay W;
- Hematti, Peiman;
- Callander, Natalie S;
- Mark, Christina J;
- Miyamoto, Shigeki;
- Alarid, Elaine T
Publication type:
Article
Ursodiol Prophylaxis against Hepatic Complications of Allogeneic Bone Marrow Transplantation.
Published in:
Annals of Internal Medicine, 1998, v. 128, n. 12, p. 975, doi. 10.7326/0003-4819-128-12_Part_1-199806150-00002
By:
- Essell, James H.;
- Schroeder, Mark T.;
- Harman, Glenn S.;
- Halvorson, Ronald;
- Lew, Vernon;
- Callander, Natalie;
- Snyder, Michael;
- Lewis, Stacey K.;
- Allerton, Jeffrey P.;
- Thompson, James M.
Publication type:
Article
Phase 2 study of dovitinib in patients with relapsed or refractory multiple myeloma with or without t(4;14) translocation.
Published in:
European Journal of Haematology, 2015, v. 95, n. 4, p. 316, doi. 10.1111/ejh.12491
By:
- Scheid, Christof;
- Reece, Donna;
- Beksac, Meral;
- Spencer, Andrew;
- Callander, Natalie;
- Sonneveld, Pieter;
- Kalimi, Ghulam;
- Cai, Can;
- Shi, Michael;
- Scott, Jeffrey W.;
- Stewart, A. Keith
Publication type:
Article
SOHO State of the Art Updates and Next Questions: Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 10, p. 653, doi. 10.1016/j.clml.2024.03.008
By:
- Schmidt, Timothy;
- Gahvari, Zhubin;
- Callander, Natalie S.
Publication type:
Article
A New Reality for Multiple Myeloma Renal Failure: US Data Report on Kidney Transplant Outcomes.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. e314, doi. 10.1016/j.clml.2021.11.002
By:
- Costa, Luciano J.;
- Lin, Yi;
- Cornell, R. Frank;
- Martin, Thomas;
- Chhabra, Saurabh;
- Usmani, Saad Z.;
- Jagannath, Sundar;
- Callander, Natalie S.;
- Berdeja, Jesus G.;
- Kang, Yubin;
- Vij, Ravi;
- Godby, Kelly N.;
- Malek, Ehsan;
- Neppalli, Amarendra;
- Liedtke, Michaela;
- Fiala, Mark;
- Tian, Hong;
- Valluri, Satish;
- Marino, Jennifer;
- Jackson, Carolyn C.
Publication type:
Article
P-201: Triple-class refractory disease as a modern therapeutic benchmark for clinical trials testing new agents for relapsed refractory Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S148, doi. 10.1016/S2152-2650(21)02328-4
By:
- Malek, Ehsan;
- Kansagra, Ankit;
- Costa, Luciano;
- Usmani, Saad Z.;
- Vij, Ravi;
- Shaji Kumar;
- Godby, Kelly;
- Bal, Susan;
- Cornell, Robert;
- Yubin Kang;
- Umyarova, Elvira;
- Giri, Smith;
- Chhabra, Saurabh;
- Callander, Natalie S.;
- Hari, Parameswaran;
- Liedtke, Michaela
Publication type:
Article
P-202: Characterization of ocular adverse events in patients receiving Belantamab Mafadotin for ≥12 months: post-hoc analysis of DREAMM-2 study in relapsed/refractory Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S149, doi. 10.1016/S2152-2650(21)02329-6
By:
- Lonial, Sagar;
- Nooka, Ajay;
- Thulasi, Praneetha;
- Badros, Ashraf Z.;
- Jeng, Bennie;
- Callander, Natalie S.;
- Sborov, Douglas;
- Zaugg, Brian E.;
- Popat, Rakesh;
- Esposti, Simona Degli;
- Baron, January;
- Doherty, Allison;
- Lewis, Eric;
- Opalinska, Joanna;
- Prani Paka;
- Piontek, Trisha;
- Gupta, Ira;
- Farooq, Asim V.;
- Jakubowiak, Andrzej
Publication type:
Article
P-212: DREAMM-5 platform trial: Belantamab mafodotin (belamaf; GSK2857916) in combination with five different novel agents in patients with relapsed/refractory multiple myeloma (RRMM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S156, doi. 10.1016/S2152-2650(21)02339-9
By:
- Richardson, Paul G.;
- Trudel, Suzanne;
- Callander, Natalie S.;
- Nooka, Ajay;
- Song, Kevin;
- Uttervall, Katarina;
- Minnema, Monique C.;
- Rodríguez-Otero, Paula;
- Struemper, Herbert;
- Yeakey, Anne;
- de Oca, Rocio Montes;
- Smith, L. Mary;
- Jackson, Nicola;
- Kaisermann, Morrys;
- Im, Ellie;
- Basile, Frank G.;
- Ahlers, Christoph M.;
- Holkova, Beata;
- Gupta, Ira;
- Kremer, Brandon E.
Publication type:
Article
OAB-052: Impact of chromosome 1 abnormalities on newly diagnosed multiple myeloma treated with proteasome inhibitor, immunomodulatory drug, and dexamethasone: analysis from the ENDURANCE ECOG-ACRIN E1A11 trial.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S33, doi. 10.1016/S2152-2650(21)02126-1
By:
- Kapoor, Prashant;
- Schmidt, Timothy;
- Jacobus, Susanna;
- Wei, Zihan;
- Fonseca, Rafael;
- Callander, Natalie S.;
- Lonial, Sagar;
- Rajkumar, S. Vincent;
- Kumar, Shaji
Publication type:
Article
OAB-051: Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone (Dara-KRd), autologous transplantation and MRD response-adapted treatment duration and cessation in newly diagnosed Multiple Myeloma (NDMM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S33, doi. 10.1016/S2152-2650(21)02125-X
By:
- Costa, Luciano;
- Chhabra, Saurabh;
- Medvedova, Eva;
- Dholaria, Bhagirathbhai;
- Schmidt, Timothy;
- Silbermann, Rebecca;
- Godby, Kelly;
- Dhakal, Binod;
- Bal, Susan;
- Giri, Smith;
- D'Souza, Anita;
- Cornell, Robert;
- Hardwick, Pamela;
- Omel, James;
- Hari, Parameswaran;
- Callander, Natalie S.
Publication type:
Article
MM-078: Characterization of Ocular Adverse Events in Patients Receiving Belantamab Mafodotin (Belamaf) for ≥12 Months: Post Hoc Analysis of DREAMM-2 Study in Relapsed/Refractory Multiple Myeloma (RRMM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S419, doi. 10.1016/S2152-2650(21)01940-6
By:
- Lonial, Sagar;
- Nooka, Ajay K.;
- Thulasi, Praneetha;
- Badros, Ashraf Z.;
- Jeng, Bennie H.;
- Callander, Natalie S.;
- Sborov, Douglas;
- Zaugg, Brian E.;
- Popat, Rakesh;
- Esposti, Simona Degli;
- Baron, January;
- Doherty, Allison;
- Lewis, Eric;
- Opalinska, Joanna;
- Paka, Prani;
- Piontek, Trisha;
- Gupta, Ira;
- Farooq, Asim V.;
- Jakubowiak, Andrzej
Publication type:
Article
Poster: MM-078: Characterization of Ocular Adverse Events in Patients Receiving Belantamab Mafodotin (Belamaf) for ≥ 12 Months: Post Hoc Analysis of DREAMM-2 Study in Relapsed/Refractory Multiple Myeloma (RRMM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S251, doi. 10.1016/S2152-2650(21)01576-7
By:
- Lonial, Sagar;
- Nooka, Ajay K.;
- Thulasi, Praneetha;
- Badros, Ashraf Z.;
- Jeng, Bennie H.;
- Callander, Natalie S.;
- Sborov, Douglas;
- Zaugg, Brian E.;
- Popat, Rakesh;
- Esposti, Simona Degli;
- Baron, January;
- Doherty, Allison;
- Lewis, Eric;
- Opalinska, Joanna;
- Paka, Prani;
- Piontek, Trisha;
- Gupta, Ira;
- Farooq, Asim V.;
- Jakubowiak, Andrzej
Publication type:
Article
CLR 131 Demonstrates High Rate of Activity in a Phase 1, Dose Escalation Study in Patients with Relapsed or Refractory Multiple Myeloma (RRMM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e356, doi. 10.1016/j.clml.2019.09.589
By:
- Longcor, Jarrod;
- Ailawadhi, Sikander;
- Oliver, Kate;
- Callander, Natalie;
- Stiff, Patrick
Publication type:
Article
Real world vs. clinical trial outcomes of triple class refractory penta-exposed multiple myeloma (MM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e115, doi. 10.1016/j.clml.2019.09.191
By:
- Cornell, Robert;
- Parameswaran, Hari;
- Tang, Shijie;
- Barnstead, Alyssa;
- Biran, Noa;
- Callander, Natalie;
- Chari, Ajai;
- Chhabra, Saurabh;
- Fiala, Mark;
- Gahvari, Zhubin;
- Gandhi, Ujjawal;
- Godby, Kelly;
- Gupta, Ridhi;
- Jagannath, Sundar;
- Jagosky, Megan;
- Kang, Yubin;
- Kansagra, Ankit;
- Kauffman, Michael;
- Kodali, Saranya;
- Kumar, Shaji
Publication type:
Article
VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study.
Published in:
2018
By:
- Chang, Julie E.;
- Carmichael, Lakeesha L.;
- Kim, KyungMann;
- Peterson, Christopher;
- Yang, David T.;
- Traynor, Anne M.;
- Werndli, Jae E.;
- Huie, Michael S.;
- McFarland, Thomas A.;
- Volk, Michael;
- Blank, Jules;
- Callander, Natalie S.;
- Longo, Walter L.;
- Kahl, Brad S.
Publication type:
journal article
Multiple Myeloma in Pregnancy--A Review of the Literature and a Case Series.
Published in:
2016
By:
- Jurczyszyn, Artur;
- Olszewska-Szopa, Magdalena;
- Vesole, Adam S.;
- Vesole, David H.;
- Siegel, David S.;
- Richardson, Paul G.;
- Paba-Prada, Claudia;
- Callander, Natalie S.;
- Huras, Hubert;
- Skotnicki, Aleksander B.
Publication type:
journal article
Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network.
Published in:
2014
By:
- Callander, Natalie;
- Markovina, Stephanie;
- Eickhoff, Jens;
- Hutson, Paul;
- Campbell, Toby;
- Hematti, Peiman;
- Go, Ronald;
- Hegeman, Robert;
- Longo, Walter;
- Williams, Eliot;
- Asimakopoulos, Fotis;
- Miyamoto, Shigeki
Publication type:
journal article
Acetyl- l-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network
Published in:
2014
By:
- Callander, Natalie;
- Markovina, Stephanie;
- Eickhoff, Jens;
- Hutson, Paul;
- Campbell, Toby;
- Hematti, Peiman;
- Go, Ronald;
- Hegeman, Robert;
- Longo, Walter;
- Williams, Eliot;
- Asimakopoulos, Fotis;
- Miyamoto, Shigeki
Publication type:
Report
Iopofosine I-131 treatment in late-line patients with relapsed/refractory multiple myeloma post anti-BCMA immunotherapy.
Published in:
Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00725-2
By:
- Longcor, Jarrod;
- Callander, Natalie;
- Oliver, Kate;
- Chanan-Khan, Asher;
- Ailawadhi, Sikander
Publication type:
Article
Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee.
Published in:
Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00695-5
By:
- Kumar, Shaji;
- Baizer, Lawrence;
- Callander, Natalie S.;
- Giralt, Sergio A.;
- Hillengass, Jens;
- Freidlin, Boris;
- Hoering, Antje;
- Richardson, Paul G.;
- Schwartz, Elena I.;
- Reiman, Anthony;
- Lentzsch, Suzanne;
- McCarthy, Philip L.;
- Jagannath, Sundar;
- Yee, Andrew J.;
- Little, Richard F.;
- Raje, Noopur S.
Publication type:
Article
Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM).
Published in:
Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00494-4
By:
- Lonial, Sagar;
- Nooka, Ajay K.;
- Thulasi, Praneetha;
- Badros, Ashraf Z.;
- Jeng, Bennie H.;
- Callander, Natalie S.;
- Potter, Heather A.;
- Sborov, Douglas;
- Zaugg, Brian E.;
- Popat, Rakesh;
- Degli Esposti, Simona;
- Byrne, Julie;
- Opalinska, Joanna;
- Baron, January;
- Piontek, Trisha;
- Gupta, Ira;
- Dana, Reza;
- Farooq, Asim V.;
- Colby, Kathryn;
- Jakubowiak, Andrzej
Publication type:
Article
Progress in the Management of Smoldering Multiple Myeloma.
Published in:
Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 172, doi. 10.1007/s11899-021-00623-7
By:
- Schmidt, Timothy M.;
- Callander, Natalie S.
Publication type:
Article
Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients.
Published in:
2022
By:
- Gasparetto, Cristina;
- Schiller, Gary J;
- Tuchman, Sascha A;
- Callander, Natalie S;
- Baljevic, Muhamed;
- Lentzsch, Suzanne;
- Rossi, Adriana C;
- Kotb, Rami;
- White, Darrell;
- Bahlis, Nizar J;
- Chen, Christine I;
- Sutherland, Heather J;
- Madan, Sumit;
- LeBlanc, Richard;
- Sebag, Michael;
- Venner, Christopher P;
- Bensinger, William I;
- Biran, Noa;
- Ammu, Sonia;
- Ben-Shahar, Osnat
Publication type:
journal article
Overall survival of patients with triple‐class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH.
Published in:
American Journal of Hematology, 2021, v. 96, n. 1, p. E5, doi. 10.1002/ajh.26010
By:
- Cornell, Robert;
- Hari, Parameswaran;
- Tang, Shijie;
- Biran, Noa;
- Callander, Natalie;
- Chari, Ajai;
- Chhabra, Saurabh;
- Fiala, Mark A.;
- Gahvari, Zhubin;
- Gandhi, Ujjawal;
- Godby, Kelly;
- Gupta, Ridhi;
- Jagannath, Sundar;
- Jagosky, Megan;
- Kang, Yubin;
- Kansagra, Ankit;
- Kauffman, Michael;
- Kodali, Saranya;
- Kumar, Shaji K.;
- Lakshman, Arjun
Publication type:
Article
MicroC<sup>3</sup>: an ex vivo microfluidic cis-coculture assay to test chemosensitivity and resistance of patient multiple myeloma cells.
Published in:
Integrative Biology, 2015, v. 7, n. 6, p. 643, doi. 10.1039/c5ib00071h
By:
- Pak, Chorom;
- Callander, Natalie S.;
- Young, Edmond W. K.;
- Titz, Benjamin;
- Kim, KyungMann;
- Saha, Sandeep;
- Chng, Kenny;
- Asimakopoulos, Fotis;
- Beebe, David J.;
- Miyamoto, Shigeki
Publication type:
Article
Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome.
Published in:
Journal of Hematology & Oncology, 2009, v. 2, p. 1, doi. 10.1186/1756-8722-2-20
By:
- Raza, Azra;
- Galili, Naomi;
- Callander, Natalie;
- Ochoa, Leonel;
- Piro, Lawrence;
- Emanuel, Peter;
- Williams, Stephanie;
- Burris III, Howard;
- Faderl, Stefan;
- Estrov, Zeev;
- Curtin, Peter;
- Larson, Richard A.;
- Keck, James G.;
- Jones, Marsha;
- Meng, Lisa;
- Brown, Gail L.
Publication type:
Article
HAPLN1 confers multiple myeloma cell resistance to several classes of therapeutic drugs.
Published in:
PLoS ONE, 2022, v. 17, n. 12, p. 1, doi. 10.1371/journal.pone.0274704
By:
- Huynh, Mailee;
- Chang, Hae Yeun;
- Lisiero, Dominique N.;
- Ong, Irene M.;
- Kashyap, Trinayan;
- Callander, Natalie S.;
- Miyamoto, Shigeki
Publication type:
Article
MAP3K8 kinase regulates myeloma growth by cell-autonomous and non-autonomous mechanisms involving myeloma-associated monocytes/macrophages.
Published in:
British Journal of Haematology, 2013, v. 160, n. 6, p. 779, doi. 10.1111/bjh.12175
By:
- Hebron, Ellen;
- Hope, Chelsea;
- Kim, Jaehyup;
- Jensen, Jeffrey L.;
- Flanagan, Claire;
- Bhatia, Neehar;
- Maroulakou, Ioanna;
- Mitsiades, Constantine;
- Miyamoto, Shigeki;
- Callander, Natalie;
- Hematti, Peiman;
- Asimakopoulos, Fotis
Publication type:
Article
Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells.
Published in:
British Journal of Haematology, 2012, v. 158, n. 3, p. 336, doi. 10.1111/j.1365-2141.2012.09154.x
By:
- Kim, Jaehyup;
- Denu, Ryan A.;
- Dollar, Bridget A.;
- Escalante, Leah E.;
- Kuether, Justin P.;
- Callander, Natalie S.;
- Asimakopoulos, Fotis;
- Hematti, Peiman
Publication type:
Article
Impact of high-risk classification by FISH: an Eastern Cooperative Oncology Group (ECOG) study E4A03.
Published in:
British Journal of Haematology, 2011, v. 155, n. 3, p. 340, doi. 10.1111/j.1365-2141.2011.08849.x
By:
- Jacobus, Susanna J.;
- Kumar, Shaji;
- Uno, Hajime;
- Van Wier, Scott A.;
- Ahmann, Greg J.;
- Henderson, Kimberly J.;
- Callander, Natalie S.;
- Williams, Michael E.;
- Siegel, David S.;
- Greipp, Philip R.;
- Rajkumar, S. Vincent;
- Fonseca, Rafael
Publication type:
Article

Found: 64